Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 2429Neoplasms 1840Carcinoma, Non-Small-Cell Lung 1615Prostatic Neoplasms 1309Colorectal Neoplasms 1147Lung Neoplasms 991Neoplasm Metastasis 836Multiple Myeloma 801Leukemia, Myeloid, Acute 777Ovarian Neoplasms 682Pancreatic Neoplasms 667Melanoma 667Squamous Cell Carcinoma of Head and Neck 592Recurrence 568Carcinoma, Hepatocellular 568Brain Neoplasms 529Glioblastoma 519Stomach Neoplasms 504Head and Neck Neoplasms 503Triple Negative Breast Neoplasms 472Lymphoma 462Uterine Cervical Neoplasms 454Carcinoma, Renal Cell 429Precursor Cell Lymphoblastic Leukemia-Lymphoma 419Lymphoma, Non-Hodgkin 392Endometrial Neoplasms 385Sarcoma 370Lymphoma, Follicular 358Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Recurrent respiratory papillomatosis × 1 year × Clear all
NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

Precigen, Inc

Phase 4 Recruiting
30 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Precigen, Inc

Phase 1/2 Active not recruiting
38 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡